Results 1 to 10 of about 9,561 (186)
Turkish Journal of Hematology, 2014 Acquired hemophilia is a rare coagulation, due to the presence of autoantibodies directed against acquired factor VIII. It remains idiopathic in almost half the cases, as in other cases, various etiologies are responsible, including some autoimmune diseases.
Şinasi Özsoylu
doaj +6 more sources
Postpartum acquired hemophilia presenting as compartment syndrome: a diagnostic challenge in the emergency department [PDF]
International Journal of Emergency MedicineBackground Acquired hemophilia A is an uncommon but potentially life-threatening bleeding disorder caused by autoantibodies against factor VIII. It can be associated with autoimmune disease, malignancy, or pregnancy. Case report We describe a 31-year-old
Waseem Mujahed +5 more
doaj +2 more sources
Acquired hemophilia A: a case report and review of the literature [PDF]
Journal of Medical Case ReportsBackground Acquired hemophilia A is a rare autoimmune disease characterized by inhibitory antibodies against coagulation factor VIII, leading to an increased risk of bleeding. The relevance of this case lies in its high associated morbidity and mortality,
Juan-Alfonso Perotti-Abad +6 more
doaj +2 more sources
Postpartum Acquired Hemophilia A. [PDF]
J Community Hosp Intern Med PerspectAcquired hemophilia A (AHA) is a bleeding disorder that occurs from aberrant production of autoantibodies that target factor VIII. The underlying cause of AHA is unclear but can present postpartum. Very few cases have reported instances of AHA coexisting with other hematological disorders, such as sickle cell trait (SCT).
Omar KO, Sebastian W, Kemper S.
europepmc +3 more sources
Atypical Postoperative Bleeding as a First Manifestation of Acquired Hemophilia A: A Case Report [PDF]
Clinical Medicine Insights: Case ReportsAcquired hemophilia A (AHA) is a rare autoimmune coagulopathy disorder characterized by the development of inhibitory autoantibodies against coagulation factor VIII.
Maciej Michalak +3 more
doaj +2 more sources
Immunotherapy of acquired hemophilia A. [PDF]
Hematology Am Soc Hematol Educ Program, 2023 Abstract Acquired hemophilia A (AHA) is an autoimmune disorder characterized by the formation of autoantibodies that neutralize the function of coagulation factor VIII. Immunosuppressive therapy (IST) with glucocorticoids, cyclophosphamide, rituximab, or combinations thereof is the standard of care to suppress autoantibody formation and ...
Tiede A.
europepmc +3 more sources
Atypical acquired hemophilia linked with primary biliary cholangitis: a unique case presentation [PDF]
Future Science OAAcquired hemophilia A is an uncommon disease often presented with bleeding episodes causing a significant mortality risk. The main responsible for the threatening hemorrhagic disorder is the Factor VIII autoantibody’s development.
Fatma Megdiche +11 more
doaj +2 more sources
Gaceta Médica de México, 2023 Acquired hemophilia (AH) is an autoimmune hemostatic disorder mediated by autoantibodies directed against factor VIII: C. In 52% of cases, the cause is unknown or is not associated with other pathological entities; in the rest, there are concomitant factors: lupus, rheumatoid arthritis, cancer, pregnancy, and medications.
Jaime, García-Chávez +1 more
openaire +2 more sources
Baylor University Medical Center Proceedings, 2019 Acquired inhibitors of coagulation are a group of rare but potentially life-threatening blood disorders characterized by the presence of autoantibodies directed against clotting factor. Autoantibody against factor VIII is the most common form of clotting factor inhibitor, a condition also known as acquired hemophilia A.
Yadav, Pandey +4 more
+7 more sources
Deferral of immunosuppression in acquired hemophilia [PDF]
Blood AdvancesJerome Teitel, Jean St-Louis
doaj +2 more sources